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Abstract
GonaCon, a single-shot injectable immunocontraceptive vaccine targeting the gonadotropin-releasing hormone (GnRH), has
been tested in key mammal species in the UK and shown to be a safe method to reduce population size in areas of high human
wildlife conflict. Badgers exhibit an unusual reproductive physiology in that females may maintain fertilised eggs and dormant
blastocysts at any time of year and delay their implantation until the winter. It is thus necessary to evaluate the consequences of
delayed implantation and timing of vaccination on the effectiveness of GonaCon for fertility control of female badgers.We found
that vaccination in June had an immediate effect on the fertility indicators monitored and inhibited subsequent cub production in
the following year, while vaccination in November had no effect. Further results suggest that the optimal vaccination window in
badgers could be as narrow as between June and August. The longer-term effectiveness of GonaCon vaccination in female
badgers appears to reflect maintenance of anti-GnRH antibody titres at or above a putative threshold titre of 1:128,000, a
threshold higher than that reported for other species (1:64,000). While it is possible that using a larger dose (> 1 mL) might lead
to longer lasting effects, this study shows that vaccination would need to be repeated at least every 2 years in order to maintain
levels of female infertility predicted to have demographic impacts on badger populations. Overall, no negative welfare conse-
quences were observed in vaccinated badgers indicating that GonaCon is a potential tool for the management of conflicts
involving badgers.
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Introduction
Fertility control offers a potential non-lethal approach for re-
ducing mammal abundance in the resolution of conflicts be-
tween wildlife and human interests (Fagerstone et al. 2010;
Massei and Cowan 2014). Compared to culling, fertility con-
trol has the potential disadvantage that it will generally take
longer to achieve equivalent population reductions, simply
because infertile animals will remain in the population until
they die (Hone 1992). However, fertility control also offers
potential advantages over culling, for example by reducing
vertical transmission of disease (mother to offspring), which
in turn reduces the probability of disease maintenance within a
population (L. A. Miller et al. 2004b). In addition, should the
body condition and general health of animals in the population
be increased following the induction of infertility (as infertile
individuals do not accrue the physiological costs of reproduc-
tion), individual susceptibility to disease should be reduced
leading to decreasing disease transmission and incidence in
the whole population. Fertility control can also result in be-
havioural changes in individuals that reduce disease contact
rates (Caley and Ramsey 2001; Dave Ramsey 2007; D. S.
Ramsey et al. 2006) and should cause less short-term social
perturbation (likely to increase disease transmission) than
culling (Tuyttens and Macdonald 1998). Fertility control can
be applied in parallel to other types of disease control inter-
ventions. It is particularly effective at maintaining populations
at an appropriate lower density after initial reduction by
culling (Merrill et al. 2003; White et al. 1997) and can poten-
tially work synergistically with disease vaccination (Carroll
et al. 2010; G. C. Smith and Cheeseman 2002) with the re-
duction in young of the year increasing the efficacy of vacci-
nation for disease control (G.C. Smith and Wilkinson 2003).
Immunocontraception, using a vaccine to generate an immune
response to some key component of the target’s reproductive
system, has moved from theory into practice with the devel-
opment of “single-shot” injectable vaccines (Curtis et al.
2002; L. A. Miller et al. 2000). This has culminated with the
f o r m u l a t i o n o f t h e s i n g l e - s h o t i n j e c t a b l e
immunocontraceptive GnRH vaccine GonaCon, registered in
the USA for white tailed-deer (Odocoileus virginianus), feral
horses (Equus caballus) and burros (Equus asinus) in the
USA. GonaCon generates antibodies to the gonadotropin-
releasing hormone (GnRH), a key hormone that regulates ste-
roid hormones (oestrogens, progesterone and testosterone).
The down-regulation of GnRH reduces levels of these hor-
mones and treated females and males can remain infertile for
several years following vaccination. GonaCon has been tested
in many mammal species and shown to be a safe and effective
single-dose GnRH-based immunocontraceptive vaccine
(Massei and Cowan 2014; Massei et al. 2008).
In the UK, bovine tuberculosis (bTB), caused byM. bovis,
is a major cattle health issue, with currently around 6.0% of
non-Officially Tuberculosis Free herds in England (12% in the
high-risk area).1 The European badger (Meles meles) is a res-
ervoir of bTB in the UK where the densities of this species are
considered to be the highest in Europe (G.C. Smith 2002). The
control of badger populations by culling has been shown to
reduce the incidence of bTB in cattle inside the culling areas
(Brunton et al. 2017; Jenkins et al. 2010). However, culling
disrupts the local badger population structure, and remaining
animals tend to move longer distances and visit neighbouring
social groups more frequently (Carter et al. 2007; R.
Woodroffe et al. 2009). This perturbation effect was associat-
ed with higher risks of bTB in surrounding cattle herds (R.
Woodroffe et al. 2009). A non-lethal approach for managing
badger populations would therefore be a potentially attractive
new strategy for reducing risks of bTB transmission from
badgers to cattle, especially if this was not expected to cause
a perturbation effect. As it is increasingly recognised that fer-
tility control and disease vaccination could complement each
other with respect to disease management (Carroll et al. 2010),
future use of fertility control in badgers could be in association
with the licenced TB vaccine for Badger BCG (Chambers
et al. 2011; Lesellier et al. 2011). Fertility control could also
be used to manage extant urban badger problems. Badger
numbers have increased in England and Wales (Judge et al.
2014), and populations have increasingly become urbanised
(S. Harris et al., 2010), in some instances causing intense and
persistent local problems (Stephen Harris 1984; Delahay et al.
2009). However, several key issues must be addressed prior to
rolling out fertility control as a new population control man-
agement method in situ: these include testing the effectiveness
and potential side effects of GonaCon in the new species (in
our case, badgers) in pilot captivity trials, monitoring the lon-
gevity of effect of GonaCon in badgers and assessing the
feasibility and cost of employing fertility control in the field.
Among mammals, badgers are characterised by an unusual
reproductive physiology. Mating can take place at any time of
year and parturition from December until July, although there
is a peak in mating behaviour from February to May, and a
peak in births from January until May. Consequently, female
badgers may be pregnant (that is, may maintain fertilised eggs
and dormant blastocysts) at any time of year. Delayed implan-
tation ensures that the vast majority of blastocysts implant
during the winter. It is therefore likely that many females
would already maintain fertilised eggs or blastocysts by the
time they could be vaccinated with GonaCon by injection,
given the recommended close season on trapping and treating
badgers which extends from December to May (Defra 2018).
Fertilised eggs and blastocysts are maintained in the lumen of
the uterus by progesterone, which is secreted by corpora lutea
1 Official detailed statistics on bTB in cattle in Great Britain published on 14/
02/2018 https://www.gov.uk/government/statistical-data-sets/tuberculosis-tb-
in-cattle-in-great-britain
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formed in the ovaries at ovulation (E. G. Neal and Harrison
1958), although at very low concentrations in comparison
with other mammals (Yamaguchi et al. 2006). Implantation
into the wall of the uterus is governed by oestrogen and pro-
gesterone, which under experimental conditions are influ-
enced by day length (Canivenc and Bonnin 1979). However,
under natural conditions, Neal and Cheeseman (1996) argued
that the high degree of within- and between-site variation in
date of implantation implies that day length (or night length)
does not provide a consistent explanatory factor. Moreover,
the ovaries secrete very little oestrogen and progesterone dur-
ing embryonic diapause and the peak period of implantation
(Page et al. 1994), which is contrary to regulation of hormone
production by exogenous cues. Neal (1977) hypothesised that
production of oestrogen and progesterone by the ovaries in
spring resulted in their uptake into body fat (steroids are sol-
uble in fat, and progesterone is known to be stored in fat in
mammals) and that the release of these hormones during win-
ter, when body fat is metabolised, promotes blastocyst implan-
tation. Ovarian progesterone (and some other hormones such
as prolactin, which is produced via a distinct hormone cas-
cade) is known to drive implantation after embryonic diapause
in American mink (Murphy et al. 1983). A major pulse in
GnRH production immediately precedes ovulation and results
in considerable production of oestrogen and progesterone, and
it is possible that this results in sufficient storage of these
steroids to promote implantation as fat is metabolised, and
hormones released during the winter. Consequently, it is pos-
sible that, if breeding badgers are treated after they had already
conceived, diapausing blastocysts will bemaintained indepen-
dently of further ovarian secretion (or rather lack of secretion
due to vaccination with GonaCon) of GnRH from active cor-
pora lutea. Corpora luteal activity is maintained independently
of hypophyseal and gonadotrophic support in some other spe-
cies that exhibit delayed implantation such as certain marsu-
pials (Hearn 1974; Hinds et al. 1983). Nevertheless, if suffi-
cient progesterone is released from body fat, implantation of
the blastocysts might in any case be independent of the hor-
mone cascade caused by GnRH secretion. Thus, the availabil-
ity of progesterone in stored fat and the continued natural
production of prolactin might allow pregnancies to go full
term.
This study directly addressed the question of whether de-
layed implantation affects the immediate impact of GonaCon
on badger fertility in captive females. The mode of action of
GonaCon can potentially reduce levels of reproductive andro-
gens, specifically testosterone, in male mammals thereby
compromising sperm production and, hence, inducing
Fig. 1 Proportion of females with at least one blastocyst identified by
ultrasound between June and December in the early vaccination, late
vaccination and control groups. The dashed lines mark the dates for the
early vaccination (green-June 2012) and the late vaccination (blue-
Nov 2012) with GonaCon. The grey shading delimits the time period of
interest for comparison between the experimental groups
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infertility. For instance, reduced testosterone and sperm counts
have been demonstrated in male cats, male dogs, and male
deer (Levy et al. 2004; Lowell A. Miller et al. 2004a). The
present study also examined the effects of GonaCon on male
badgers because during application of GonaCon by injection
in the field, it would be difficult to reliably discriminate be-
tween males and females in traps. Furthermore, although male
infertility is likely to be relatively unimportant demographi-
cally, it might augment reduced female fertility in terms of
additional reductions in cub production.
This study initially established breeding in captive badgers
before monitoring their reproductive physiology and cub pro-
duction over 2 years following a single inoculation with
GonaCon vaccine. The objectives of the study were
1. To evaluate the consequences of delayed implantation and
timing of vaccination on the effectiveness of GonaCon for
fertility control in female badgers.
2. To evaluate the longevity of infertility induced by
GonaCon in female badgers by determining the putative
titre level below which infertility is reversed.
3. To monitor potential negative side effects associated with
GonaCon in both male and female badgers.
Methods
Study animals
Study animals were obtained from areas where bTB is not
endemic in cattle and is not known to persist in badgers.
Individuals were given a full health check on being brought
into captivity, and blood samples were collected for biochem-
ical assessment. Each individual was uniquely marked with a
PIT tag. All animals tested negative for bTB using the IFNγ
ELISA (enzyme-linked immunosorbent assay) Immuno-
Assay (EIA) (Dalley et al. 2008).
The animals were housed at a Good Laboratory
Practice (GLP) compliant specialist animal facility in en-
closures each consisting of a solid roofed and concreted
area measuring 8 m * 5 m with access to a mesh roofed
grassed area of 20 m by 5 m. Each enclosure included six
wooden lidded enclosed shelters (“setts”) and was
enriched with an assortment of digging and burrowing
opportunities as well as pools. Two males and two fe-
males were housed in each enclosure; individuals were
randomly assigned to enclosures irrespective of their
treatment group. A complex feeding regime was
Fig. 2 Variation in mean (± SE) uterine diameter (mm) for the early
vaccination, late vaccination and control groups. The dashed lines mark
the dates for the early vaccination (green-June 2012) and the late
vaccination (blue-Nov 2012) with GonaCon. The grey shading delimits
the time period of interest for comparison between the experimental
groups
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employed to ensure emotional and physical enrichment
through feeding.
Study design and treatments
Initially, 20 adult females were allocated to three treatment
groups: early vaccination (n = 7), late vaccination (n = 7) and
control (unvaccinated, n = 6). The terms “early” and “late”
reflect the approximate earliest and latest times of year when
application in the field could occur under the current UK close
season (December to May) for licenced badger trapping. Each
individual in the early vaccination group was treated in the
first week of June whilst the late vaccination group was treated
in the first week of November 2012. In both cases, each indi-
vidual received a single 1-mL dose containing 1000 μg of
GonaCon. The vaccine was administered by deep intra mus-
cular injection into the quadriceps femoris muscle, approxi-
mately 1 cm anterior to the mid shaft of the femur. The same
batch of GonaCon was used for both treatment groups (6-
month storage is approved under the current EPA registration
for GonaCon). Additional animals were recruited to the con-
trol group which consequently increased in size (to n = 10)
during the study. Post-vaccination, the animals were closely
monitored for any side effects (defined as anything untoward
found during veterinary examinations or observed by animal
care staff) over the duration of the study (June 2012 to
November 2015).
Twenty males were randomly allocated to a “Vaccinated”
group (n = 11) or a “Control” group (n = 9), with the former
receiving an intramuscular injection of a single 1-mL dose
containing 1000 μg of GonaCon in June 2014.
Monitoring of physiology and fertility
All females were anesthetised every 4–5 weeks between
June and February each year of the study (2012, 2013
and 2014), except for January 2013, 2014 and 2015 and
December 2014 due to concerns about anaesthetising
torpid badgers during periods of relatively low ambient
temperatures. All males were anaesthetized once per
month between August and November 2014 and in
March 2015. Badgers were anaesthetised intramuscular-
ly, either in the hind limb or para-lumbar musculature,
using the anaesthetic described in De Leeuw et al.
(2004).
At each examination, individuals were weighed and health
checked, and a sample of blood was collected from every
animal and then centrifuged to separate and freeze the serum.
Fig. 3 Variation in mean (± SE) serum progesterone levels (ng/mL) for
females in the early vaccination, late vaccination and control groups. The
dashed lines mark the dates for the early vaccination (green-June 2012)
and the late vaccination (blue-Nov 2012) with GonaCon. The grey shad-
ing delimits the time period of interest for comparison between the ex-
perimental groups
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Fig. 4 Variation in mean (± SE) anti-GnRH antibody titres in the early (green-June 2012) and late (blue-Nov 2012) vaccination groups
Fig. 5 Variation in mean (± SE) anti-GnRH antibody titres in males after vaccination with GonaCon
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The area around the injection sites of each vaccinated
individual was palpated. Progesterone and cortisol (as a
measure of physiological stress) levels in female blood
serum samples were measured by ELISA using validat-
ed kits (DX-EIA-1561 Progesterone 96 Well, DX-EIA-
1887 Cortisol 96 Well, Immunodiagnosticsystems Ltd.,
UK), while blood samples from males were analysed for
testosterone concentration (protocol described in
Buesching et al. (2009)). Anti-GnRH antibody titres in
all spun blood serum samples were quantified using an
indirect ELISA technique based on that described by
Miller et al. (2000), Levy et al. (2004) and Bender
et al. (2009) and specifically adapted for the badger as
described in Supplementary Information file 1. The
titres are reported as the highest 1:X,000 dilution at
which antibodies were detected.
Testicular status of males was assessed as described by
Woodroffe and Macdonald (1995). Ultrasound examina-
tion of anaesthetised female badgers was undertaken to
assess and measure reproductive structures (cervix, uter-
ine body and bifurcation into the left and right uterine
horns ) . The presence of embryos (ea r ly pos t -
implantation with head indistinct from body) and foetuses
(head and body distinct and measurable with ossification
sometimes apparent) was noted. Examples of ultrasound
imaging can be found in Supplementary Information 2.
Five variables were considered to be indicators of fertility
in female badgers as follows:
Table 1 Summary of anti-GnRH antibody titre levels in vaccinated females that produced litters, and those that did not, over the course of three
reproductive cycles
2013- Early 
vaccination group
2013- Late vaccination 
group
2014- Vaccinated group 2015- Vaccinated group
Number 
of 
females 
that 
littered
Number 
of females 
that did 
not litter
Number 
of females 
that 
littered
Number 
of females 
that did 
not litter
Number of 
vaccinated 
females that 
littered
Number of 
vaccinated 
females that 
did not litter
Number of 
vaccinated 
females that 
littered
Number of 
vaccinated 
females that 
did not litter
0 6 6 1 3 7 3 7
Titres* of 
females 
that have 
littered 
Titres* of 
females 
that did 
not litter
Titres* of 
females 
that have 
littered
Titres* of 
females 
that did 
not litter
Titres* of 
females that 
have littered 
Titres* of 
females that 
did not litter
Titres* of 
females that 
have littered
Titres* of 
females that 
did not litter
NA 1 female 
1:32,000
2 females 
1:128,00
2 females 
1:256,000
1 female 
1:512,000
2 females 
1:32,000
3 females 
1:256,000
1 female 
1:512,000
1 female 
1:512,000
1 female 
1:8,000
1 female 
1:16,000
1 female 
1;64,000
1 female 
1:32,000
2 females 
1:64,000
2 females 
1:128,00
2 females 
1:256,000
1 females 
1:64,000
2 females 
1:512,000
1 female no 
detectable 
titres
2 females 
1:8,000
2 females 
1:32,000
1 female 
1:256,000
1 female 
1:512,000
*Measured in February when pregnancy status of females could be ascertained by ultrasound
# These females had been revaccinated in September 2014 when their previous titre levels had fallen to 1:32,000
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(a) the presence of one or more blastocysts during any ultra-
sound observation undertaken between June and
December (peak dates for blastocysts).
(b) uterine diameter between December and February (peak
dates for pregnancy-)
(c) progesterone serum level greater than 7 ng/mL in a
February blood serum sample.
(d) one or more embryos or foetuses present at a February
ultrasound examination.
(e) litter known to have been produced in February orMarch
(peak dates for birth)
Statistical analyses
In order to evaluate the consequences of delayed implantation
and timing of vaccination on the effectiveness of GonaCon in
inducing infertility in the following breeding season (i.e. up to
March 2013), female fertility indicators were in a first instance
compared between (A) the control group and the early vacci-
nation group and (B) the control group and the late vaccina-
tion group. Post-March 2013, the early vaccination and late
vaccination female groups were pooled together for analysis.
Proportions between treatment groups (e.g. proportion of
female with embryos, with > 1 blastocysts…) were compared
using Fisher’s exact test. A two-sample t test was used to
compare the means of normally distributed continuous vari-
ables (body weight) between the vaccinated and the control
groups. A Mann-Whitney U test was used for non-normally
distributed continuous variables (uterine diameter, testoster-
one, testis status index). P values were adjusted for multiple
comparisons, when appropriate, by controlling the false dis-
covery rate as proposed by Benjamini and Hochberg (1995).
Given the small sample sizes in this study, we expect the
power of the statistical tests (defined as the probability of
rejecting the null hypothesis—of no difference between the
treatment groups—when it is in fact wrong) to be very low.
As such, our results should be interpreted with the necessary
caution.
As initial data exploration provided anecdotal evidence of a
putative titre fertility threshold of GonaCon of 1:128,000 (see
results), we further investigated the effect of titre levels on the
various fertility indicators in the longer term (i.e. post
March 2013) by comparing females with high titre levels
(1:128,000 and above) to females with low titre levels
(1:64,000 and below). To evaluate the longevity of the female
infertility induced by GonaCon, the time between vaccination
and the second consecutive anti-GnRH antibody titre assay
reading below 1:128,000 was used to fit a Cox proportional-
hazards model (Cox 1972) to (A) investigate the association
Fig. 6 Variation in mean (± SE) uterine diameter (mm) in females with high (1:128,000 and above) and low (1:64,000 and below) titres. The grey
shading delimits the time period of interest for comparison between the experimental groups
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between the time to reaching the putative titre fertility thresh-
old and the timing of vaccination (early vs. late vaccination
groups) and (B) determine the median time taken for titres in
females to fall below this threshold.
All analyses and figures were produced in R (R Core Team
2017) using the following packages: here (Müller 2017),
ggplot2 (Hadley Wickham 2009), dplyr (Hadley Wickham
et al. 2017), scales (Hadley Wickham 2017), survival
(Therneau 2015), survminer (Kassambara and Kosinski
2018), tidyr (Hadley Wickham and Henry 2017) and zoo
(Zeileis and Grothendieck 2005).
Results
Effects of delayed implantation on the effectiveness
of GonaCon in inducing female infertility
the following breeding season
No blastocysts were identified in any females in the early
vaccination group during 2012 (Fig. 1). One month post-vac-
cination, 2/7 females in the late vaccinated group showed
signs of blastocysts, compared to 3/6 females in the control
group (Fisher’s exact p > 0.99).
There was a statistically significant difference in uterine
diameter between the control (n = 6) and the early vaccinated
groups (n = 7) in July 2012 (W = 35, adj. p = 0.02) (Fig. 2).
Differences in August, September and November 2012 al-
though non-significant were borderline (0.05 < adj. p < 0.07).
However, we found no statistically significant difference in
uterine diameter between the two groups in December 2012
(W = 25, adj. p = 0.59) or February 2013 (W = 29, adj. p =
0.13) which should represent peak pregnancy months.
Similarly, there was no statistically significant differences in
uterine diameter between the control (n = 6) and late vaccina-
tion (n = 7) groups in December 2012 (W = 17.5, adj. p =
0.87), February 2013 (W = 22, adj. p = 0.95) or other time
points up to March 2013 (all adjusted p values > 0.27).
Progesterone levels were higher in the control group com-
pared to the early vaccinated group in August 2012 (W = 41,
adj. p = 0.04), but no difference was found for all other time
points (all adj. p > 0.17, Fig. 3). No differences in progester-
one levels between the control and late vaccinated groups
were detected throughout the entire period leading up to
March 2013 (all adj. p > 0.30).
No embryos or foetuses were identified in any females in
the early vaccination group in February 2013. Embryos/
foetuses were identified in 2/7 females in the late vaccination
group in February 2013 (3 months post-vaccination) and in 3/
Fig. 7 Variation in mean (± SE) serum progesterone levels (ng/mL) for females in females with high (1:128,000 and above) and low (1:64,000 and
below) titres. The grey shading delimits the time period of interest for comparison between the experimental groups
Eur J Wildl Res           (2019) 65:59 Page 9 of 18    59 
6 control females (3/6) (Fisher’s exact p = 0.59). None of the
six surviving individuals in the early vaccination group (one
female died under anaesthesia in December 2012) gave birth
in February or March 2013. However, litters were born in
February or March 2013 to 6/7 females in the late vaccination
group, compared to 3/6 control females (Fisher’s exact p =
0.27).
Anti-GnRH antibody titres and longevity of reduced
fecundity
All females in both the early and late vaccination groups (and
none, as expected, in the control group) expressed anti-GnRh
antibody titres 1 month after vaccination. In two females (one
in the early and one in the late vaccination group), titres quick-
ly decreased from 1:256,000 1 month post-vaccination to
1:64,000 and 1:32,000, respectively, within 2 months. In all
other individuals, the titres gradually declined (Fig. 4) to the
extent that by February 2013 (8 months post-vaccination and
3 months post-vaccination for the early and late vaccination
groups, respectively), 1/6 early vaccination group females and
2/7 in the late vaccination group had titres below 1:64,000,
threshold below which fertility is compromised in other spe-
cies such as wild boar and white-tailed deer (L. A. Miller et al.
2008; Massei et al. 2012).
Nine out of the 10 males vaccinated had measurable anti-
GnRH antibody titres 2 months later. However, one individual
showed no response at any time after vaccination. The mean
titres declined with time post-vaccination (Fig. 5) but were
still apparent in March 2015 (9 months post-vaccination) for
the other nine males, at which time six had titres of at least
1:64,000.
In 2013, none of the six early vaccination females littered,
with five individuals showing titres of 1:128,000 and above in
February 2013, month of the ultrasound that ascertained that
some of (treated and control) females were pregnant (Table 1).
The sixth female did not litter despite low levels of titres.
Interestingly, four of the six late vaccination females that
littered in 2013 had titres of 1:256,000 and above in
February 2013, suggesting that vaccination in November
may be too late into the reproductive cycle to induce immedi-
ate infertility.
By 2014, a further three vaccinated females had died (two
from the early and one from the late vaccination groups). Post
mortem examinations did not indicate any causes of death
attributable to GonaCon vaccination. The February anti-
GnRH antibody titres of the three vaccinated females that
produced litters that year were in all cases equal or inferior
to 1:64,000 (Table 1). Four of the seven vaccinated females
that did not produce a litter in 2014 had titres of 1:128,000 and
Fig. 8 Survival curves based on Kaplan-Meier estimates of the time
between vaccination and two consecutive anti-GnRH assay titre readings
below the putative fertility threshold of 1;128,000. The number of
censoring represents females that died over the course of the study and
for which the last reading gave titre levels of 1:128,000 or above
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above, while three showed titres of 1:64,000 and below. A
similar pattern was found in 2015 with only two of the seven
vaccinated females that did not produce a litter that year show-
ing titres of 1:128,000 and above. The situation in 2015 is
compounded by the fact that three females with titre levels
of 1:32,000 or below were revaccinated mid-September
2014. Despite all three subsequently showing high
(1:512,000) levels of titres 1 month post-vaccination, two of
these females produced litters in 2015, further suggesting that
the time window to administer the vaccine and successfully
induce infertility in the following year could be as narrow as
June–August. If we leave the revaccinated individuals aside,
no treated female badgers with titres above 1:128,000 pro-
duced a litter over the 3 years of the study, suggesting that
the putative fertility threshold for GonaCon in badgers may be
higher (titre levels above 1:128,000) than that observed in
other mammalian species.
Further anecdotal evidence of a putative 1:128,000 anti-
GnRH antibody titre threshold for fertility is found by consid-
ering other indicators. For example, 0/4 females with high
titres (1:128,000 and above) showed observable embryos/
foetuses during ultrasounds carried out in February 2014,
compared to 3/6 females with lower titres (1:64,000 and be-
low). Difference in median uterine diameter between females
with high and with low titres were borderline significant in
September 2013 (W = 9 adj. p = 0.054), December 2013 (W =
14 adj. p = 0.054) and February 2014 (W = 17.5 adj. p = 0.07)
(Fig. 6). Progesterone levels were higher in females with low
titres compared to those with high titres (Fig. 7) in September
2013 (W = 6, p = 0.017) and in February 2014 (W = 5, p =
0.003).
The timing of vaccination (early June or late November)
had no significant effect (Wald test p = 0.88) on the longevity
of the response as measured by the time to two consecutive
titre readings below 1:128,000 (Fig. 8). When both early and
late vaccination groups were combined, the median longevity
(as defined above) was 647 days.
Monitoring of possible side effects of GonaCon
injection in male and female badgers
We observed no difference in testosterone levels (Fig. 9, all
adj. p > 0.99) between vaccinated and control males through-
out their follow-up post-vaccination in June 2014. Although
the mean testis status index of vaccinated males appeared to
decline more markedly in vaccinated males, relative to that of
controls males, during autumn and winter (Fig. 10), we found
no statistically significant difference in testis status index
throughout the follow-up period (all adj. p values > 0.12).
Fig. 9 Variation in mean (± SE) serum testosterone levels (ng/mL) for males in the vaccinated and control groups. The dashed line marks the date of the
vaccination (June 2014) with GonaCon
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Apart from transient lameness in some animals, no side
effects were noted. We found no statistically significant dif-
ferences in cortisol levels between the control and the early
vaccinated groups (all adj. p > 0.67) in the two samples taken
prior to injection and during the 2 months post-treatment. A
similar pattern was found when comparing the control and late
vaccination group (all adj. p > 0.99) (Fig. 11). We also found
no statistically significant differences in the body weight of
females (all adj. p > 0.77, Fig. 12) and males (Fig. 13, all adj.
p > 0.17) between the control and the vaccinated groups
throughout the entire period under study.
Discussion
At approximately 1 month after vaccination all treated females
had anti-GnRH antibody titres greater than those typically
associated with reduced fertility in other species (L. A.
Miller et al. 2008; Gray et al. 2010; Massei et al. 2012).
These other fertility control studies will, in some cases, have
used species-specific agents and slightly different methodolo-
gies to read titre levels although we do not expect those to
affect the relative sensitivities of the assays. The rapid onset of
titres and the effect on reproductive physiology were reflected
in the relatively small uterine diameter of the early vaccination
group in July 2012, 1 month after their vaccination. In con-
trast, the uterine diameters in the control group were highest at
this time which is consistent with descriptions of the uterine
endometrium assuming a secretory appearance from this time
(Bonnin-Laffargue 1964). It is possible that absence of this
function in the early vaccinated individuals, as a consequence
of the June vaccinations, would have compromised subse-
quent maintenance of blastocysts.
The novel use of ultrasound to monitor pre-implantation
reproductive physiology in the badger extended to the suc-
cessful recognition of blastocysts. However, it was only pos-
sible to observe by ultrasound approximately two-thirds of the
uterine tract, with the rest being obscured by other tissues.
Hence, the numbers of blastocysts detected will have
underestimated the actual numbers present. Nevertheless,
some blastocysts were detected in at least some of the control
and late vaccination groups at each of the five sampling points
between July and December 2012 while, in contrast, no blas-
tocysts were found in any of the early vaccination group dur-
ing this period. This suggested that either inhibition of blasto-
cyst production and/or maintenance of blastocyst during this
period occurred in the early vaccination group. The immediate
effect of vaccination on productivity was confirmed by the
absence of litters in the early vaccination group in the follow-
ing February or March, compared to confirmed litters born to
Fig. 10 Variation in median testis status index for males in the vaccinated and control groups. The dashed line marks the date of the vaccination
(June 2014) with GonaCon
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six out of the seven late vaccination group females and three
out the six unvaccinated group females. We concluded that
early vaccination had an immediate effect and inhibited sub-
sequent cub production, despite the potential for delayed im-
plantation of any pre-existing fertilised blastocysts, but the late
vaccination did not.
The higher progesterone levels observed in control
females in August 2012, relative to the early vaccina-
tion group, are consistent with the biphasic seasonal
variation in progesterone levels in badgers described
by Bonnin et al. (1978). This modest rise in progester-
one during the summer has been suggested to be of
ovarian origin because of the increase in luteal size
and progesterone content observed in September by
Canivenc et al. (1966). It is thus probable that this rise
in progesterone could be affected by targeting GnRH
with GonaCon and, hence, the immediate negative effect
on reproduction brought about by the June vaccinations.
However, the absence of an immediate effect of the
November vaccinations on reproduction in the late vac-
cination group indicates that the second phase of pro-
gesterone increase, beginning just prior to implantation,
was not affected by inhibiting the GnRH. Canivenc and
Bonnin (1981) describe a process of luteal reactivation
from October through to December associated with
increases in the size and progesterone content of badger
luteal tissue and this reactivation is associated with in-
creasing luteinising hormone (LH) levels during this pe-
riod. Furthermore, LH levels are raised more by ovari-
ectomy in October than in April, indicating that the
pituitary is more sensitive to declines in circulating
ovarian products towards the end of the period of de-
layed implantation. What influences such sensitivity is
unclear. However, Bonnin et al. (1984) describe a high-
affinity binding protein, specifically corticosteroid bind-
ing globulin (CBG), present in badger plasma whose
level is substantially raised in September which they
suggest might involve a pituitary factor. Such a factor
will not necessarily be regulated by GnRH and thus
may not be amenable to manipulation by a vaccine
targeting this hormone. Hence, once the process involv-
ing such a factor is underway this will lead inexorably
to the implantation of existing blastocysts, and vaccina-
tion in November will thus be too late to inhibit cub
production. We also observed that a second vaccination
of three females in September 2014 failed to prevent
litter production in 2015 and, hence, was already too
late for immediate effectiveness. If the rise in CBG in
September is an indicator of the initiation of a process
that is mediated by GnRH then it is possible that
Fig. 11 Variation in mean (± SE) serum cortisol levels (ng/mL) for females in the early vaccination, late vaccination and control groups. The dashed lines
mark the dates for the early vaccination (green-June 2012) and the late vaccination (blue-Nov 2012) with GonaCon
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vaccination prior to this onset might have an immediate
effect on subsequent cub production. The effective vac-
cination period, given the existing close season on bad-
ger trapping, may thus be between June and August.
The longer-term effectiveness of GonaCon vaccination in
female badgers appears to reflect maintenance of anti-GnRH
antibody titres at or above a putative threshold titre of
1:128,000. Furthermore, by the end of the third post-
vaccination breeding season, there was no evidence of any
effects on overall fertility with only one out of four vaccinated
females having anti-GnRH antibody titres above the putative
infertility threshold. Hence, although the initial strength and
frequency of immune responses to GonaConwere comparable
to those seen in other species, the maintenance of titres at or
above the threshold was shorter. Variation between individ-
uals in the longevity of responses to GonaCon vaccination,
despite consistently high initial antibody titres, has been re-
ported for other species, including the domestic cat (Levy
et al. 2011). The reasons for this variation are unknown. The
longevity of the response to GonaCon is considered to derive
from the combination of a large carrier protein containing
numerous T cell epitopes, a mineral oil emulsion and the use
of an adjuvant containingM. avium (L. A. Miller et al. 2008).
The granulomatous injection-site reactions frequently report-
ed following GonaCon vaccination, typical of an adjuvanted
vaccine, may be important for the generation of long-term
responses. For instance, these were not found in cats with
relatively short-lived responses but were found in some
long-term responding individuals (Levy et al. 2011). In this
context it is potentially relevant that badgers are reported to
exhibit relatively modest granulomatous reactions to bTB
(Gavier-Widen et al. 2001), albeit similar to those in other
carnivores such as cats. It is possible that using a larger dose
might lead to longer lasting effects but this would require
further studies and further monitoring of potential injection
site reaction. Otherwise it appears that vaccination would need
to be repeated at least every 2 years in order to maintain levels
of female infertility predicted to have demographic impacts on
badger populations (Cowan and Massei 2008).
Overall no negative welfare consequences were observed
in vaccinated female badgers. However, as Hampton et al.
(2015) point out, fertility control can have many and varied
welfare consequences. Further, they contend that preservation
of hormonal competence is important to maximise the welfare
of wild animals and thus argue against the use of endocrine
suppression mechanisms, including compromising GnRH ac-
tivity. On the other hand, many seasonally breeding species,
including the badger, will spend significant amounts of their
normal lives down-regulated with respect to reproductive en-
docrinology. Furthermore, such considerations need to be
Fig. 12 Variation in mean body weights (± SE) of females in the vaccinated and control groups
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compared directly with the welfare consequences of other
management tools, such as culling (Kirkpatrick 2007;
Massei and Cowan 2014).
We found no evidence of any immediate impact of vacci-
nation on the fertility of males. Reducing the fertility of males
is demographically less important than doing so in females.
Nevertheless, in field vaccination programmes, undertaken
using cage trapping without anaesthesia, it is unlikely that
reliable determination of the sex of treated individuals would
be feasible, so it is useful that this study has not identified any
negative welfare consequences of vaccination in male
badgers.
The reduction in female fertility generated by vaccination
with GonaCon indicates potential as a tool for the manage-
ment of conflicts involving badgers. So far, the most success-
ful cases of demographic regulation of populations using fer-
tility control come from applications involving small, closed
populations of readily accessible species (Ransom et al.
(2014b). Where culling badgers is not locally acceptable, ex-
clusion is problematic and the conflict is substantial, the cost
of applying fertility control through injection may well be the
most economic answer (e.g. damage to urban structures where
excluded badger would have nowhere to move to). But fertil-
ity control on its own could take a long time to suppress a
population For badgers, rather than impacting large-scale
demography, there is potential to complement BCG vaccina-
tion to control bTB by reducing the recruitment of new sus-
ceptible animals into vulnerable populations. BCG is currently
being used as part of the UK Government strategy for bTB
control and this approachmay be applied muchmore widely if
it becomes used as part of an exit strategy to the ongoing
badger culling. In this scenario, the economic cost of using
GonaCon would be minimal given the animals will be trapped
and vaccinated anyway, and the efficacy of control could be
substantially higher given that the population has already been
reduced. In this situation, GonaCon would be used to reduce
the rate of population recovery. Epidemiological modelling
could potentially predict what proportions of individuals
would need to be vaccinated to help reduce bTB prevalence.
However, these predictions would still have to be tested in the
field, including exploring possible effects on individual
movements and social structure. For instance, Ransom et al.
(2014a) observed that female horses vaccinated with a GnRh
immunocontraceptive fed less, rested more, travelled less and
performed more maintenance behaviours than controls, but
engaged in the same amount of social behaviour. These dif-
ferences were commensurate with the higher metabolic de-
mands of pregnancy and lactation. Conversely, GonaCon did
not affect social and spatial behaviour in Eastern fox squirrels
(Sciurus niger (Krause et al. 2015)) and in wild boar (Massei
Fig. 13 Variation in mean (± SE) body weight (kg) for males in the vaccinated and control groups. The dashed line marks the date of the vaccination
(June 2014) with GonaCon
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et al. 2008; Quy et al. 2014). How such factors might influ-
ence the complex social structure of the badger and, in partic-
ular, interaction rates in the context of disease transmission
would be important questions to address. Furthermore, possi-
ble interactions between the efficacy of the badger BCG and
GonaCon vaccines would need to be evaluated, especially
given potential for interaction with the M. avium adjuvant
component of the GonaCon vaccine.
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